ROIV

Healthcare

Roivant Sciences Ltd.

$28.14-0.41 (-1.44%)

Prev Close

$28.55

Open

$28.87

High

$29.23

Low

$28.02

Volume

2.26M

Market Cap

$19.80B

P/E

—

Div Yield

—

Over the past 12 months, insider activity at Roivant Sciences Ltd. (ROIV) has been exclusively selling, with 0 insider purchases totaling $0.00 and 2 insider sales totaling $87.34M. The most recent insider transaction was by Torti Frank (President and Vant Chair), who sold $82.04M worth of shares on Feb 19, 2026. Roivant Sciences Ltd. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $19.80B.

Buys (12M)

$0.00

Sells (12M)

$87.34M

Net Activity

Net Seller

$87.34M

Active Insiders

last 12 mo

ROIV Price Chart

ROIV Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Feb 19, 2026↗	Torti Frank	President and Vant Chair	Sell	3,000,000	$27.35	$82.04M	0
Feb 13, 2026↗	Venker Eric	President & Immunovant CEO	Sell	200,000	$26.49	$5.30M	0

ROIV Insider Buying Activity

The following table shows recent insider purchases of Roivant Sciences Ltd. (ROIV) stock reported via SEC Form 4 filings.

No insider buying activity found for ROIV in the last 12 months.

ROIV Insider Selling Activity

The following table shows recent insider sales of Roivant Sciences Ltd. (ROIV) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Feb 19, 2026↗	Torti Frank	President and Vant Chair	Sell	3,000,000	$27.35	$82.04M	0
Feb 13, 2026↗	Venker Eric	President & Immunovant CEO	Sell	200,000	$26.49	$5.30M	0